Quidel Receives CE Mark for Its Sofia Strep A Fluorescent Immunoassay Test

by Benzinga Staff
December 1, 2011 1:47 PM | 27 seconds read | Make a Comment

27% profit every 20 days?

This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.

Quidel Corporation(NASDAQ: QDEL), a leading provider of diagnostic testing solutions,announced today that it has received the CE Mark for its Sofia StrepA FIA for use with its Sofia Analyzer. Sofia is the brand name for Quidel's next generation, immunoassaysystem. The Sofia Analyzer and Sofia Strep A FIA combine uniquefluorescent chemistry, advanced lateral flow technology, and failurealert and fail-safe systems to ensure a reliable, objective, rapidand highly accurate diagnostic result. This press release followsclosely on the recent announcement (October 26th) of the FDAclearance of the Sofia Analyzer and Sofia Influenza A+B FIA.

27% profit every 20 days?

This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.

ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

Posted In: NewsEvents

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.